Which peptides are in this family?
-
BPC-157Body Protection Compound-157
Synthetic gastric-derived peptide studied in animal models of tissue healing. Not licensed in the UK; human evidence is one small uncontrolled study.
LimitedNot licensed in the UK -
GHK-CuCopper peptide GHK
Copper-binding tripeptide studied for skin ageing and wound healing. Topical cosmetic use; no licensed injectable product in the UK.
LimitedNot licensed in the UK -
TB-500Thymosin Beta-4 fragment
Short synthetic fragment linked to thymosin beta-4. Not licensed in the UK. No human trials of TB-500 itself were found; trials of the full-length protein are not evidence for it.
LimitedNot licensed in the UK -
Thymosin beta-4Thymosin β4
Natural 43-amino-acid peptide studied in eye and wound-healing trials. Not licensed in the UK. Trials were small with mixed results. It is not TB-500.
LimitedNot licensed in the UK
Best recorded finding for each peptide in this family
Each row grades one recorded finding, not the peptide or the medicine.
| Peptide | UK status | Finding | Evidence grade |
|---|---|---|---|
| BPC-157 | Not licensed in the UK | Systematic review of 36 studies | Limited |
| GHK-Cu | Not licensed in the UK | Fibrillin-1 deposition over six months | Limited |
| TB-500 | Not licensed in the UK | 2026 scoping review, 80 studies | Limited |
| Thymosin beta-4 | Not licensed in the UK | Neurotrophic keratopathy Phase III | Limited |
Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.